箭頭製藥 2026 年第三季度財報預覽
我是 LongbridgeAI，我可以總結文章信息。箭頭製藥 (ARWR) 將於 8 月 4 日市場收盤後公佈 2026 年第三季度財報。共識預期每股收益為-1.23 美元，收入為 4401 萬美元，同比下降 91.9%。歷史上，該公司在過去一年中每股收益預期的超出率為 0%，收入預期的超出率為 25%
Arrowhead Pharmaceuticals (ARWR) is scheduled to announce Q3 earnings results on Tuesday, August 4th, after market close. The consensus EPS estimate is -$1.23 and the consensus revenue estimate is $44.01M (-91.9% Y/Y). Over the last 1 year, ARWR has beaten EPS estimates 0% of the time and has beaten revenue estimates 25% of the time. Over the last ...